Product Information

PIOGLITAZONE HCL 45 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1144 per EA under NDC 57237022190. Its NADAC has been published 451 times since Nov 8, 2017.

PIOGLITAZONE HCL 45 MG TABLET

Pioglitazone
$0.1144per EA

Strength

45 mg/1

NDC

57237022190

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA200268

On Market Since

2/13/2013

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 45 MG TABLET has been published 451 times since Nov 8, 2017, and over the history we have for it it has declined 32.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1144 per EA
All-time high$0.1794 (Jan 13, 2021)
All-time low$0.0964 (Nov 20, 2024)
52-week high$0.1305
52-week low$0.1124
Median price$0.1402
Average price$0.1412
Largest weekly change-26.2% (Nov 20, 2024)
Weeks tracked451
Tracking sinceNov 8, 2017

Price History

1W

0.0%

1M

-4.3%

3M

-0.1%

6M

-3.5%

1Y

-12.3%

3Y

-21.9%

5Y

-31.1%

All

-32.3%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 45 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 45 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1144 per EA (NDC 57237022190), effective Jun 24, 2026.

How has the price of PIOGLITAZONE HCL 45 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has declined 32.3%. It has been tracked across 451 weekly CMS publications since Nov 8, 2017.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 45 MG TABLET?

Since Nov 8, 2017, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has ranged from a low of $0.0964 (Nov 20, 2024) to a high of $0.1794 (Jan 13, 2021), with a median of $0.1402 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 45 MG TABLET?

5 NADAC-published products share the same active ingredient, strength, and dosage form as PIOGLITAZONE HCL 45 MG TABLET, but none are currently priced below it.

Who manufactures PIOGLITAZONE HCL 45 MG TABLET?

PIOGLITAZONE HCL 45 MG TABLET (NDC 57237022190) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.